Phathom Pharmaceuticals, Inc. (PHAT)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

100 CAMPUS DRIVE, FLORHAM PARK, NJ 07932

Phathom Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company focuses on development and commercialization for gastrointestinal (GI) diseases and disorder treatments. Phathom Pharmaceuticals serves gastrointestinal and pharmaceutical industries in the State of Illinois.

Data as of 2021-05-08 12:05:13 -0400
Market Cap1.095 Billion Shares Outstanding31.322 Million Avg 30-day Volume90.07 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-7.9 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.50738 52-week High/Low64.54 / 28.1 Next Earnings Date2021-05-11 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from PHAT instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 7 -28.57% 3 (0.18%) 4 (0.25%) -25.0%
Funds Holding: 77 58 32.76% 26 (1.56%) 14 (0.87%) 85.71%
13F shares: 24.534 Million 21.373 Million 14.79% 11.2 Million 10.54 Million 6.26%
% Ownership 87.1054 82.4687 5.62% 39.7647 40.6701 -2.23%
New Positions: 25 2 1150.0% 13 1 1200.0%
Increased Positions 21 11 90.91% 4 2 100.0%
Closed Positions 5 5 0.0% 1 1 0.0%
Reduced Positions 15 24 -37.5% 5 5 0.0%
Total Calls 10.8 Thousand 0
Total Puts 14.701 Thousand 0
PUT/CALL Ratio 1.36
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding PHAT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PHAT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

122.1 Thousand total shares from 29 transactions

Exercise Derivative Conversion (M)

11.5 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TAKEDA PHARMACEUTICAL CO LTD

  • 10% Owner
1,042,870 2021-05-05 2

NABULSI AZMI CHIEF OPERATING OFFICER

  • Officer
765,700 2021-05-03 9

SOCKS DAVID A

  • Director
1,341,048 2021-04-05 7

CURRAN TERRIE PRESIDENT AND CHIEF EXECUTIVE

  • Officer
  • Director
855,687 2021-03-22 3

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • 10% Owner
3,115,008 2021-03-11 1

BRANNING TODD P. CHIEF FINANCIAL OFFICER

  • Officer
0 2021-01-28 3

FRAZIER LIFE SCIENCES IX, L.P.

FHMLS IX, L.P.

FHMLS IX, L.L.C.

TOPPER JAMES N

HERON PATRICK J

  • Director
  • 10% Owner
5,858,861 2020-06-12 1

COLA MICHAEL F

  • Director
0 2020-05-21 1

FIELDS HEIDI

  • Director
0 2020-05-21 1

YAMADA TADATAKA

  • Director
0 2020-05-21 1

TOPPER JAMES N

  • Director
  • 10% Owner
0 2020-05-21 1

STENHOUSE MARK

  • Director
0 2020-03-17 0

PARIKH ASIT

  • Director
0 2019-12-02 0

EDWARDS JONATHAN S.

  • Director
3,083,091 2019-10-29 0

KOHLI ADITYA CHIEF BUSINESS OFFICER

  • Officer
843,352 2019-10-24 0

SLAVINSKY CHRISTOPHER W.

  • Director
0 2019-10-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

TAKEDA PHARMACEUTICAL CO LTD - > 10% Owner

2021-05-07 07:22:17 -0400 2021-05-06 S 202 $35.01 d 1,042,870 direct yes

TAKEDA PHARMACEUTICAL CO LTD - > 10% Owner

2021-05-07 07:22:17 -0400 2021-05-05 S 6,936 $35.14 d 1,043,072 direct yes

TAKEDA PHARMACEUTICAL CO LTD - > 10% Owner

2021-05-05 08:26:25 -0400 2021-05-04 S 4,690 $36.21 d 1,053,608 direct yes -3.8297 0.0 1 -3.8297 2

NABULSI AZMI - Officer CHIEF OPERATING OFFICER by trust

2021-05-04 20:31:21 -0400 2021-05-04 S 1,400 $37.09 d 766,789 indirect -3.8297 0.0 1 -3.8297 2

TAKEDA PHARMACEUTICAL CO LTD - > 10% Owner

2021-05-05 08:26:25 -0400 2021-05-04 S 100 $38.53 d 1,050,008 direct yes -3.8297 0.0 1 -3.8297 2

TAKEDA PHARMACEUTICAL CO LTD - > 10% Owner

2021-05-05 08:26:25 -0400 2021-05-04 S 11,070 $35.50 d 1,058,298 direct yes -3.8297 0.0 1 -3.8297 2

NABULSI AZMI - Officer CHIEF OPERATING OFFICER by trust

2021-05-04 20:31:21 -0400 2021-05-04 S 1,968 $36.15 d 768,189 indirect -3.8297 0.0 1 -3.8297 2

TAKEDA PHARMACEUTICAL CO LTD - > 10% Owner

2021-05-05 08:26:25 -0400 2021-05-04 S 3,500 $37.47 d 1,050,108 direct yes -3.8297 0.0 1 -3.8297 2

NABULSI AZMI - Officer CHIEF OPERATING OFFICER by trust

2021-05-04 20:31:21 -0400 2021-05-04 S 1,089 $37.86 d 765,700 indirect -3.8297 0.0 1 -3.8297 2

TAKEDA PHARMACEUTICAL CO LTD - > 10% Owner

2021-05-05 08:26:25 -0400 2021-05-03 S 11,272 $38.45 d 1,069,571 direct yes -3.8297 0.0 1 -3.8297 2

NABULSI AZMI - Officer CHIEF OPERATING OFFICER by trust

2021-05-04 20:31:21 -0400 2021-05-03 S 4,290 $37.85 d 775,910 indirect yes -3.8297 0.0 1 -3.8297 2

TAKEDA PHARMACEUTICAL CO LTD - > 10% Owner

2021-05-05 08:26:25 -0400 2021-05-03 S 3,157 $37.60 d 1,080,843 direct yes -3.8297 0.0 1 -3.8297 2

TAKEDA PHARMACEUTICAL CO LTD - > 10% Owner

2021-05-05 08:26:25 -0400 2021-05-03 S 203 $39.06 d 1,069,368 direct yes -3.8297 0.0 1 -3.8297 2

NABULSI AZMI - Officer CHIEF OPERATING OFFICER by trust

2021-05-04 20:31:21 -0400 2021-05-03 S 5,753 $38.59 d 770,157 indirect -3.8297 0.0 1 -3.8297 2

SOCKS DAVID A - Director david a. socks 2013 revocable trust

2021-04-07 16:13:34 -0400 2021-04-06 S 3,359 $35.97 d 1,354,068 indirect -0.1815 -4.0456 1.0633 4 -4.0456 6

SOCKS DAVID A - Director david a. socks 2013 revocable trust

2021-04-07 16:13:34 -0400 2021-04-06 S 6,795 $38.03 d 1,340,945 indirect -0.1815 -4.0456 1.0633 4 -4.0456 6

SOCKS DAVID A - Director david a. socks 2013 revocable trust

2021-04-07 16:13:34 -0400 2021-04-06 S 1,400 $34.96 d 1,357,427 indirect -0.1815 -4.0456 1.0633 4 -4.0456 6

SOCKS DAVID A - Director david a. socks 2013 revocable trust

2021-04-07 16:13:34 -0400 2021-04-06 S 6,328 $37.37 d 1,347,740 indirect -0.1815 -4.0456 1.0633 4 -4.0456 6

SOCKS DAVID A - Director david a. socks 2013 revocable trust

2021-04-07 16:13:34 -0400 2021-04-05 S 7,769 $36.40 d 1,360,557 indirect -0.1815 -4.0456 1.0633 4 -4.0456 6

NABULSI AZMI - Officer CHIEF OPERATING OFFICER by trust

2021-04-05 19:01:15 -0400 2021-04-05 S 4,316 $36.37 d 780,985 indirect 1.4405 2.0691 2.0691 6 -0.4715 5

SOCKS DAVID A - Director david a. socks 2013 revocable trust

2021-04-07 16:13:34 -0400 2021-04-05 S 12,619 $35.69 d 1,368,326 indirect yes -0.1815 -4.0456 1.0633 4 -4.0456 6

NABULSI AZMI - Officer CHIEF OPERATING OFFICER by trust

2021-04-05 19:01:15 -0400 2021-04-05 S 4,252 $35.66 d 785,301 indirect 1.4405 2.0691 2.0691 6 -0.4715 5

SOCKS DAVID A - Director david a. socks 2013 revocable trust

2021-04-07 16:13:34 -0400 2021-04-05 S 1,730 $37.15 d 1,358,827 indirect -0.1815 -4.0456 1.0633 4 -4.0456 6

NABULSI AZMI - Officer CHIEF OPERATING OFFICER by trust

2021-04-05 19:01:15 -0400 2021-04-05 S 785 $37.11 d 780,200 indirect 1.4405 2.0691 2.0691 6 -0.4715 5

NABULSI AZMI - Officer CHIEF OPERATING OFFICER by trust

2021-04-05 19:01:15 -0400 2021-04-01 S 3,405 $37.28 d 791,295 indirect yes 1.4405 2.0691 2.0691 6 -0.4715 5

NABULSI AZMI - Officer CHIEF OPERATING OFFICER by trust

2021-04-05 19:01:15 -0400 2021-04-01 S 1,742 $38.14 d 789,553 indirect 1.4405 2.0691 2.0691 6 -0.4715 5

CURRAN TERRIE - Director - Officer PRESIDENT AND CHIEF EXECUTIVE

2021-03-23 19:22:06 -0400 2021-03-22 S 10,373 $43.24 d 1,140 direct yes 2.1292 -7.0067 -16.6873 2.1292 2 -16.6873 31

CURRAN TERRIE - Director - Officer PRESIDENT AND CHIEF EXECUTIVE

2021-03-23 19:22:06 -0400 2021-03-22 M 11,513 d 855,687 direct

CURRAN TERRIE - Director - Officer PRESIDENT AND CHIEF EXECUTIVE

2021-03-23 19:22:06 -0400 2021-03-22 M 11,513 $6.95 a 11,513 direct 2.1292 -7.0067 -16.6873 2.1292 2 -16.6873 31

CURRAN TERRIE - Director - Officer PRESIDENT AND CHIEF EXECUTIVE

2021-03-23 19:22:06 -0400 2021-03-22 S 1,140 $44.08 d 0 direct 2.1292 -7.0067 -16.6873 2.1292 2 -16.6873 31

SOCKS DAVID A - Director david a. socks 2013 revocable trust

2021-03-12 17:54:40 -0500 2021-03-12 S 500 $46.67 d 1,380,945 indirect -1.7857 -2.9911 -11.0268 0.0 1 -20.9821 26

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 22:15:04 UTC -0.4423 0.4923 350000
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 21:45:02 UTC -0.4423 0.4923 350000
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 21:15:02 UTC -0.4423 0.4923 350000
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 20:45:03 UTC -0.4423 0.4923 350000
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 20:15:03 UTC -0.4423 0.4923 350000
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 19:45:03 UTC -0.4423 0.4923 350000
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 19:15:03 UTC -0.4423 0.4923 350000
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 18:45:03 UTC -0.4423 0.4923 350000
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 18:15:03 UTC -0.4423 0.4923 350000
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 17:45:02 UTC -0.4423 0.4923 350000
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 17:15:03 UTC -0.4423 0.4923 350000
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 16:45:03 UTC -0.4393 0.4893 350000
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 16:15:03 UTC -0.4393 0.4893 350000
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 15:45:03 UTC -0.4393 0.4893 300000
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 15:15:03 UTC -0.4393 0.4893 300000
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 14:45:04 UTC -0.4393 0.4893 300000
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 14:15:04 UTC -0.4393 0.4893 300000
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 13:45:04 UTC -0.4393 0.4893 300000
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 13:15:03 UTC -0.4393 0.4893 300000
PHATHOM PHARMACEUTICALS INC PHAT 2021-05-10 12:45:02 UTC -0.4393 0.4893 300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund PHAT -1249.0 shares, $-49160.64 2020-10-31 N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund PHAT -673.0 shares, $-22357.06 2020-12-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST- 361 Global Long/Short Equity Fund PHAT -7656.0 shares, $-294756.0 2021-01-31 N-PORT

Elevate your investments